TapewireFind a company

organization · Reporting owner

NB ALTERNATIVES ADVISERS LLC

Disclosed activity across 28 companies

Tapewire entity
76353
SEC CIK
0001469000

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
BIORA THERAPEUTICS, INC.PROG · Entity 8504710% ownerJune 14, 2021June 14, 2021
EXCELSIOR VENTURE PARTNERS III LLCN/A · Entity 13521Investment Sub-AdviserAugust 14, 2015June 12, 2018
N-able, Inc.NABL · Entity 520310% ownerJuly 19, 2021July 28, 2021
NB Crossroads Private Markets Fund IV (TE) - Client LLCN/A · Entity 87738Investment Sub-AdviserDecember 18, 2015June 12, 2018
NB Crossroads Private Markets Fund IV (TI) - Client LLCN/A · Entity 87740Investment Sub-AdviserDecember 18, 2015June 12, 2018
NB Crossroads Private Markets Fund IV Holdings LLCN/A · Entity 87739Investment Sub-AdviserDecember 18, 2015June 12, 2018
NB Crossroads Private Markets Fund V (TE) Advisory LPN/A · Entity 87714Investment Sub-AdviserAugust 22, 2017June 12, 2018
NB Crossroads Private Markets Fund V (TE) LPN/A · Entity 87717Investment Sub-AdviserApril 07, 2017June 12, 2018
NB Crossroads Private Markets Fund V (TI) Advisory LPN/A · Entity 87713Investment Sub-AdviserAugust 22, 2017June 12, 2018
NB Crossroads Private Markets Fund V (TI) LPN/A · Entity 87715Investment Sub-AdviserApril 07, 2017June 12, 2018
NB Crossroads Private Markets Fund V Holdings LPN/A · Entity 87716Investment Sub-AdviserApril 07, 2017June 12, 2018
NB Crossroads Private Markets Fund VI Advisory LPN/A · Entity 87711Investment Sub-AdviserFebruary 14, 2020February 19, 2020
NB Crossroads Private Markets Fund VI Custody LPN/A · Entity 151559Investment Sub-AdviserFebruary 14, 2020February 19, 2020
NB Crossroads Private Markets Fund VI Holdings LPN/A · Entity 87710Investment Sub-AdviserFebruary 14, 2020February 19, 2020
NB Crossroads Private Markets Fund VI LPN/A · Entity 87712Investment Sub-AdviserFebruary 14, 2020February 19, 2020
NB Crossroads Private Markets Fund VII Holdings LPNONE · Entity 87746Investment Sub-AdviserFebruary 14, 2022March 11, 2022
NB Crossroads Private Markets Fund VII LPNONE · Entity 87745Investment Sub-AdviserFebruary 14, 2022March 11, 2022
NB Private Markets Access Fund LLCNONE · Entity 87744Investment Sub-AdviserDecember 15, 2020December 15, 2020
NB Private Markets Fund II (Master) LLCN/A · Entity 13112Investment Sub-AdviserAugust 06, 2015June 12, 2018
NB Private Markets Fund II (TE) LLCN/A · Entity 13114Investment Sub-AdviserAugust 06, 2015June 12, 2018
NB Private Markets Fund II (TI) LLCN/A · Entity 13113Investment Sub-AdviserAugust 06, 2015June 12, 2018
NB Private Markets Fund III (Master) LLCN/A · Entity 87727Investment Sub-AdviserAugust 06, 2015June 12, 2018
NB Private Markets Fund III (TE) LLCN/A · Entity 87726Investment Sub-AdviserAugust 06, 2015June 12, 2018
NB Private Markets Fund III (TI) LLCN/A · Entity 87728Investment Sub-AdviserAugust 06, 2015June 12, 2018
Neuberger Asset-Based Credit FundNONE · Entity 24692Investment Sub-AdviserAugust 19, 2025August 19, 2025
SolarWinds CorpSWI · Entity 8069110% ownerDecember 10, 2020December 14, 2020
UST Global Private Markets Fund, LLCN/A · Entity 13484Investment Sub-AdviserAugust 06, 2015June 12, 2018

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee footnotes36,396,907 Reported balance After 2021-06-14 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2021-06-14 · Purchase · Acquired 8,097,166 · Balance 36,396,907

F1: The shares of the Issuer's common stock and the Warrant were purchased for $2.47 per unit, with each unit consisting of one share of the Issuer's common stock and the right to buy an additional share of the Issuer's common stock for the exercise price specified in the Warrant.

F2: The 8,097,166 shares of the Issuer's common stock and the Warrant are directly owned by Athyrium Opportunities III Acquisition 2 LP. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities III Acquisition 2 LP. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC. Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and the President of Athyrium Opportunities Associates III GP LLC.

F3: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $2.84 · Expires 2026-06-14IndirectSee footnotes8,097,166 Reported balance After 2021-06-14 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2021-06-14 · Purchase · Acquired 8,097,166 · Balance 8,097,166

F4: The Warrant represents a right to buy 8,097,166 shares of the Issuer's common stock at an exercise price of $2.84 per share. The Warrant is exercisable at any time and from time to time prior to June 14, 2026.

F1: The shares of the Issuer's common stock and the Warrant were purchased for $2.47 per unit, with each unit consisting of one share of the Issuer's common stock and the right to buy an additional share of the Issuer's common stock for the exercise price specified in the Warrant.

F2: The 8,097,166 shares of the Issuer's common stock and the Warrant are directly owned by Athyrium Opportunities III Acquisition 2 LP. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities III Acquisition 2 LP. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC. Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and the President of Athyrium Opportunities Associates III GP LLC.

F3: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: The shares of the Issuer's common stock and the Warrant were purchased for $2.47 per unit, with each unit consisting of one share of the Issuer's common stock and the right to buy an additional share of the Issuer's common stock for the exercise price specified in the Warrant.

F2: The 8,097,166 shares of the Issuer's common stock and the Warrant are directly owned by Athyrium Opportunities III Acquisition 2 LP. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities III Acquisition 2 LP. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC. Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and the President of Athyrium Opportunities Associates III GP LLC.

F3: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.

F4: The Warrant represents a right to buy 8,097,166 shares of the Issuer's common stock at an exercise price of $2.84 per share. The Warrant is exercisable at any time and from time to time prior to June 14, 2026.

EXCELSIOR VENTURE PARTNERS III LLC

Report date August 14, 2015 · Filed June 12, 2018

This filing explicitly reported no securities owned.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee footnotes2,479,735 Reported balance Holding disclosure · report date 2021-07-19 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 2,479,735

F1: This Form 3 is filed jointly by NB Alternatives Advisers LLC ("NBAA"), NB Crossroads XX - MC Holdings LP ("NB Crossroads XX LP"), NB Crossroads XXI - MC Holdings LP ("NB Crossroads XXI LP"), NB - Iowa's Public Universities LP ("NB IPU LP"), NB PEP Holdings Limited ("NB PEP"), NB RP Co-Investment & Secondary Fund LLC ("NB RP Co-Investment"), NB Sonoran Fund Limited Partnership ("NB Sonoran LP"), NB Strategic Co-Investment Partners II Holdings LP ("NB Co-Investment II Holdings"), NB Wildcats Fund LP ("NB Wildcats LP"), Neuberger Berman Insurance Fund Series Interests of the SALI Multi-Series Fund, L.P. ("NB SALI Series") and TfL Trustee Company Limited as Trustee of the TfL Pension Fund ("TfL Trustee") (collectively, the "Reporting Persons").

F2: To enable all of the Reporting Persons to gain access to the Securities and Exchange Commission's electronic filing system (which only accepts a maximum of 10 joint filers per report), this report is the first of two identical reports relating to the same holdings. Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the outstanding shares of N-able, Inc. (the "Issuer"). Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. Neither the filing of this report nor anything herein shall be deemed an admission that any Reporting Person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose, the beneficial owner of such securities.

F3: Consists of (i) 198,379 shares held directly by NB Crossroads XX LP, (ii) 74,392 shares held directly by NB Crossroads XXI LP, (iii) 49,595 shares held directly by NB IPU LP, (iv) 173,581 shares held directly by NB PEP, (v) 49,595 shares held directly by NB RP Co-Investment, (vi) 49,595 shares held directly by NB Sonoran LP, (vii) 1,487,841 shares held directly by NB Co-Investment II Holdings, (viii) 49,595 shares held directly by NB Wildcats LP, (ix) 99,189 shares held directly by NB SALI Series and (x) 247,973 shares held directly by TfL Trustee.

F4: NBAA exercises dispositive and voting power with respect to the shares held by each of the other Reporting Persons and, as a result, may be deemed to beneficially own the shares held directly by NB Crossroads XX LP, NB Crossroads XXI LP, NB IPU LP, NB PEP, NB RP Co-Investment, NB Sonoran LP, NB Co-Investment II Holdings, NB Wildcats LP, NB SALI Series and TfL Trustee.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 3 is filed jointly by NB Alternatives Advisers LLC ("NBAA"), NB Crossroads XX - MC Holdings LP ("NB Crossroads XX LP"), NB Crossroads XXI - MC Holdings LP ("NB Crossroads XXI LP"), NB - Iowa's Public Universities LP ("NB IPU LP"), NB PEP Holdings Limited ("NB PEP"), NB RP Co-Investment & Secondary Fund LLC ("NB RP Co-Investment"), NB Sonoran Fund Limited Partnership ("NB Sonoran LP"), NB Strategic Co-Investment Partners II Holdings LP ("NB Co-Investment II Holdings"), NB Wildcats Fund LP ("NB Wildcats LP"), Neuberger Berman Insurance Fund Series Interests of the SALI Multi-Series Fund, L.P. ("NB SALI Series") and TfL Trustee Company Limited as Trustee of the TfL Pension Fund ("TfL Trustee") (collectively, the "Reporting Persons").

F2: To enable all of the Reporting Persons to gain access to the Securities and Exchange Commission's electronic filing system (which only accepts a maximum of 10 joint filers per report), this report is the first of two identical reports relating to the same holdings. Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the outstanding shares of N-able, Inc. (the "Issuer"). Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. Neither the filing of this report nor anything herein shall be deemed an admission that any Reporting Person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose, the beneficial owner of such securities.

F3: Consists of (i) 198,379 shares held directly by NB Crossroads XX LP, (ii) 74,392 shares held directly by NB Crossroads XXI LP, (iii) 49,595 shares held directly by NB IPU LP, (iv) 173,581 shares held directly by NB PEP, (v) 49,595 shares held directly by NB RP Co-Investment, (vi) 49,595 shares held directly by NB Sonoran LP, (vii) 1,487,841 shares held directly by NB Co-Investment II Holdings, (viii) 49,595 shares held directly by NB Wildcats LP, (ix) 99,189 shares held directly by NB SALI Series and (x) 247,973 shares held directly by TfL Trustee.

F4: NBAA exercises dispositive and voting power with respect to the shares held by each of the other Reporting Persons and, as a result, may be deemed to beneficially own the shares held directly by NB Crossroads XX LP, NB Crossroads XXI LP, NB IPU LP, NB PEP, NB RP Co-Investment, NB Sonoran LP, NB Co-Investment II Holdings, NB Wildcats LP, NB SALI Series and TfL Trustee.

NB Crossroads Private Markets Fund IV (TE) - Client LLC

Report date December 18, 2015 · Filed June 12, 2018

This filing explicitly reported no securities owned.

NB Crossroads Private Markets Fund IV (TI) - Client LLC

Report date December 18, 2015 · Filed June 12, 2018

This filing explicitly reported no securities owned.

NB Crossroads Private Markets Fund IV Holdings LLC

Report date December 18, 2015 · Filed June 12, 2018

This filing explicitly reported no securities owned.

NB Crossroads Private Markets Fund V (TE) Advisory LP

Report date August 22, 2017 · Filed June 12, 2018

This filing explicitly reported no securities owned.

NB Crossroads Private Markets Fund V (TE) LP

Report date April 07, 2017 · Filed June 12, 2018

This filing explicitly reported no securities owned.

NB Crossroads Private Markets Fund V (TI) Advisory LP

Report date August 22, 2017 · Filed June 12, 2018

This filing explicitly reported no securities owned.

NB Crossroads Private Markets Fund V (TI) LP

Report date April 07, 2017 · Filed June 12, 2018

This filing explicitly reported no securities owned.

NB Crossroads Private Markets Fund V Holdings LP

Report date April 07, 2017 · Filed June 12, 2018

This filing explicitly reported no securities owned.

NB Crossroads Private Markets Fund VI Advisory LP

Report date February 14, 2020 · Filed February 19, 2020

This filing explicitly reported no securities owned.

NB Crossroads Private Markets Fund VI Custody LP

Report date February 14, 2020 · Filed February 19, 2020

This filing explicitly reported no securities owned.

NB Crossroads Private Markets Fund VI Holdings LP

Report date February 14, 2020 · Filed February 19, 2020

This filing explicitly reported no securities owned.

NB Crossroads Private Markets Fund VI LP

Report date February 14, 2020 · Filed February 19, 2020

This filing explicitly reported no securities owned.

NB Crossroads Private Markets Fund VII Holdings LP

Report date February 14, 2022 · Filed March 11, 2022

This filing explicitly reported no securities owned.

NB Crossroads Private Markets Fund VII LP

Report date February 14, 2022 · Filed March 11, 2022

This filing explicitly reported no securities owned.

NB Private Markets Access Fund LLC

Report date December 15, 2020 · Filed December 15, 2020

This filing explicitly reported no securities owned.

NB Private Markets Fund II (Master) LLC

Report date August 06, 2015 · Filed June 12, 2018

This filing explicitly reported no securities owned.

NB Private Markets Fund II (TE) LLC

Report date August 06, 2015 · Filed June 12, 2018

This filing explicitly reported no securities owned.

NB Private Markets Fund II (TI) LLC

Report date August 06, 2015 · Filed June 12, 2018

This filing explicitly reported no securities owned.

NB Private Markets Fund III (Master) LLC

Report date August 06, 2015 · Filed June 12, 2018

This filing explicitly reported no securities owned.

NB Private Markets Fund III (TE) LLC

Report date August 06, 2015 · Filed June 12, 2018

This filing explicitly reported no securities owned.

NB Private Markets Fund III (TI) LLC

Report date August 06, 2015 · Filed June 12, 2018

This filing explicitly reported no securities owned.

Neuberger Asset-Based Credit Fund

Report date August 19, 2025 · Filed August 19, 2025

This filing explicitly reported no securities owned.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee footnote4,959,467 Reported balance After 2020-12-10 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2020-12-10 · Sale · Disposed 289,066 · Balance 4,959,467

F1: This Form 4 is filed jointly by NB Alternatives Advisers LLC ("NBAA"), NB Crossroads XX - MC Holdings LP ("NB Crossroads XX LP"), NB Crossroads XXI - MC Holdings LP ("NB Crossroads XXI LP"), NB - Iowa's Public Universities LP ("NB IPU LP"), NB PEP Holdings Limited ("NB PEP"), NB RP Co-Investment & Secondary Fund LLC ("NB RP Co-Investment"), NB Sonoran Fund Limited Partnership ("NB Sonoran LP"), NB Strategic Co-Investment Partners II Holdings LP ("NB Co-Investment II Holdings"), NB Wildcats Fund LP ("NB Wildcats LP"), Neuberger Berman Insurance Fund Series Interests of the SALI Multi-Series Fund L.P. ("NB SALI Series") and TfL Trustee Company Limited as Trustee of the TfL Pension Fund ("TfL Trustee") (collectively, the "Reporting Persons").

F2: To enable all of the Reporting Persons to gain access to the Securities and Exchange Commission's electronic filing system (which only accepts a maximum of 10 joint filers per report), this report is the first of two identical reports relating to the same transactions. Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the outstanding shares of SolarWinds Corporation (the "Issuer"). Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. Neither the filing of this report nor anything herein shall be deemed an admission that any Reporting Person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose, the beneficial owner of such securities.

F3: On December 10, 2020, the Reporting Persons executed a joinder to a Stock Purchase Agreement to sell shares of common stock at a price of $21.97 per share, subject to potential adjustment under certain circumstances.

F4: Consists of (i) 23,125 shares sold by NB Crossroads XX LP, (ii) 8,672 shares sold by NB Crossroads XXI LP, (iii) 5,781 shares sold by NB IPU LP, (iv) 20,235 shares sold by NB PEP, (v) 5,781 shares sold by NB RP Co-Investment, (vi) 5,781 shares sold by NB Sonoran LP, (vii) 173,440 shares sold by NB Co-Investment II Holdings, (viii) 5,781 shares sold by NB Wildcats LP, (ix) 11,563 shares sold by NB SALI Series and (x) 28,907 shares sold by TfL Trustee.

F5: Consists of (i) 396,757 shares held directly by NB Crossroads XX LP, (ii) 148,783 shares held directly by NB Crossroads XXI LP, (iii) 99,190 shares held directly by NB IPU LP, (iv) 347,162 shares held directly by NB PEP, (v) 99,190 shares held directly by NB RP Co-Investment, (vi) 99,190 shares held directly by NB Sonoran LP, (vii) 2,975,681 shares held directly by NB Co-Investment II Holdings, (viii) 99,190 shares held directly by NB Wildcats LP, (ix) 198,378 shares held directly by NB SALI Series and (x) 495,946 shares held directly by TfL Trustee.

F6: NBAA exercises dispositive and voting power with respect to the shares held by each of the other Reporting Persons and, as a result, may be deemed to beneficially own the shares held directly by NB Crossroads XX LP, NB Crossroads XXI LP, NB IPU LP, NB PEP, NB RP Co-Investment, NB Sonoran LP, NB Co-Investment II Holdings, NB Wildcats LP, NB SALI Series and TfL Trustee.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 is filed jointly by NB Alternatives Advisers LLC ("NBAA"), NB Crossroads XX - MC Holdings LP ("NB Crossroads XX LP"), NB Crossroads XXI - MC Holdings LP ("NB Crossroads XXI LP"), NB - Iowa's Public Universities LP ("NB IPU LP"), NB PEP Holdings Limited ("NB PEP"), NB RP Co-Investment & Secondary Fund LLC ("NB RP Co-Investment"), NB Sonoran Fund Limited Partnership ("NB Sonoran LP"), NB Strategic Co-Investment Partners II Holdings LP ("NB Co-Investment II Holdings"), NB Wildcats Fund LP ("NB Wildcats LP"), Neuberger Berman Insurance Fund Series Interests of the SALI Multi-Series Fund L.P. ("NB SALI Series") and TfL Trustee Company Limited as Trustee of the TfL Pension Fund ("TfL Trustee") (collectively, the "Reporting Persons").

F2: To enable all of the Reporting Persons to gain access to the Securities and Exchange Commission's electronic filing system (which only accepts a maximum of 10 joint filers per report), this report is the first of two identical reports relating to the same transactions. Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the outstanding shares of SolarWinds Corporation (the "Issuer"). Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. Neither the filing of this report nor anything herein shall be deemed an admission that any Reporting Person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose, the beneficial owner of such securities.

F3: On December 10, 2020, the Reporting Persons executed a joinder to a Stock Purchase Agreement to sell shares of common stock at a price of $21.97 per share, subject to potential adjustment under certain circumstances.

F4: Consists of (i) 23,125 shares sold by NB Crossroads XX LP, (ii) 8,672 shares sold by NB Crossroads XXI LP, (iii) 5,781 shares sold by NB IPU LP, (iv) 20,235 shares sold by NB PEP, (v) 5,781 shares sold by NB RP Co-Investment, (vi) 5,781 shares sold by NB Sonoran LP, (vii) 173,440 shares sold by NB Co-Investment II Holdings, (viii) 5,781 shares sold by NB Wildcats LP, (ix) 11,563 shares sold by NB SALI Series and (x) 28,907 shares sold by TfL Trustee.

F5: Consists of (i) 396,757 shares held directly by NB Crossroads XX LP, (ii) 148,783 shares held directly by NB Crossroads XXI LP, (iii) 99,190 shares held directly by NB IPU LP, (iv) 347,162 shares held directly by NB PEP, (v) 99,190 shares held directly by NB RP Co-Investment, (vi) 99,190 shares held directly by NB Sonoran LP, (vii) 2,975,681 shares held directly by NB Co-Investment II Holdings, (viii) 99,190 shares held directly by NB Wildcats LP, (ix) 198,378 shares held directly by NB SALI Series and (x) 495,946 shares held directly by TfL Trustee.

F6: NBAA exercises dispositive and voting power with respect to the shares held by each of the other Reporting Persons and, as a result, may be deemed to beneficially own the shares held directly by NB Crossroads XX LP, NB Crossroads XXI LP, NB IPU LP, NB PEP, NB RP Co-Investment, NB Sonoran LP, NB Co-Investment II Holdings, NB Wildcats LP, NB SALI Series and TfL Trustee.

UST Global Private Markets Fund, LLC

Report date August 06, 2015 · Filed June 12, 2018

This filing explicitly reported no securities owned.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Section 16 reporting ended · disclosed 2023-05-19. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeIndirectSee footnote2,700,975 Reported balance After 2023-05-16 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2023-05-16 · Sale · Disposed 4,181,906 · Balance 2,700,975

F1: This Form 4 is filed jointly by NB Alternatives Advisers LLC ("NBAA"), NB Crossroads Private Markets Fund V Holdings LP ("NB Private Markets V"), NB Crossroads XXII - MC Holdings LP ("NB Crossroads XXII"), NB Gemini Fund LP ("NB Gemini"), and NB Select Opps II MHF LP ("NB Select Opps II") (collectively, the "Reporting Persons").

F2: The Reporting Persons state that neither the filing of this statement nor anything herein shall be deemed an admission that such persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise, the beneficial owners of any securities covered by this statement. The Reporting Persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such persons in such securities.

F3: The Reporting Persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to Solo Brands, Inc. (the "Issuer") or securities of the Issuer.

F4: On May 16, 2023, pursuant to an underwriting agreement (the "Underwriting Agreement"), which is attached as Exhibit 1.1 to the Issuer's Form 8-K filed with the Securities and Exchange Commission (the "SEC") on May 12, 2023, entered into by the Issuer in connection with a registered secondary offering and sale of shares of Class A common stock of the Issuer, $0.001 par value per share ("Shares") by NB Private Markets V, NB Crossroads XXII, NB Gemini, and NB Select Opps II (collectively, the "NB Parties") and certain other selling stockholders listed on Schedule B to the Underwriting Agreement, the underwriters purchased from the NB Parties at a purchase price of $5.25 per share, less the underwriters' discount of $0.25 per share,

F5: (Continued from footnote 4) (the "Offering Price"), (i) 209,087 Shares, that were held directly by NB Private Markets V, (ii) 543,653 Shares that were held directly by NB Crossroads XXII, (iii) 1,610,040 Shares that were held directly by NB Gemini, and (iv) 1,819,126 Shares that were held directly by NB Select Opps II.

F6: Consists of (i) 135,043 Shares, held directly by NB Private Markets V, (ii) 351,130 Shares held directly by NB Crossroads XXII, (iii) 1,039,879 Shares held directly by NB Gemini, and (iv) 1,174,923 Shares held directly by NB Select Opps II.

F7: NBAA exercises dispositive and voting power with respect to the Shares held by each of the other Reporting Persons and, as a result, may be deemed to beneficially own the Shares held directly by each of NB Private Markets V, NB Crossroads XXII, NB Gemini, and NB Select Opps II.

Class A Common StockSEC Table I · non-derivativeIndirectSee footnote627,286 Reported balance After 2023-05-16 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 2 · 2023-05-16 · Sale · Disposed 2,073,689 · Balance 627,286

F1: This Form 4 is filed jointly by NB Alternatives Advisers LLC ("NBAA"), NB Crossroads Private Markets Fund V Holdings LP ("NB Private Markets V"), NB Crossroads XXII - MC Holdings LP ("NB Crossroads XXII"), NB Gemini Fund LP ("NB Gemini"), and NB Select Opps II MHF LP ("NB Select Opps II") (collectively, the "Reporting Persons").

F2: The Reporting Persons state that neither the filing of this statement nor anything herein shall be deemed an admission that such persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise, the beneficial owners of any securities covered by this statement. The Reporting Persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such persons in such securities.

F3: The Reporting Persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to Solo Brands, Inc. (the "Issuer") or securities of the Issuer.

F8: In addition, on May 16, 2023, pursuant to a privately negotiated Stock Purchase Agreement (the "Purchase Agreement"), which is attached as Exhibit 10.1 to the Issuer's Form 8-K filed with the SEC on May 12, 2023, by and between the Issuer, the NB Parties and certain other selling stockholders, the Issuer repurchased from the NB Parties at a purchase price of equal to the Offering Price, (i) 103,680 Shares that were held directly by NB Private Markets V, (ii) 269,582 Shares that were held directly by NB Crossroads XXII, (iii) 798,373 Shares that were held directly by NB Gemini, and (iv) 902,054 Shares that were held directly by NB Select Opps II.

F9: Consists of (i) 31,363 Shares, held directly by NB Private Markets V, (ii) 81,548 Shares held directly by NB Crossroads XXII, (iii) 241,506 Shares held directly by NB Gemini, and (iv) 272,869 Shares held directly by NB Select Opps II. As a result of the transactions by the NB Parties pursuant to the Purchase Agreement and the Underwriting Agreement, the Reporting Persons will no longer be reporting persons.

F7: NBAA exercises dispositive and voting power with respect to the Shares held by each of the other Reporting Persons and, as a result, may be deemed to beneficially own the Shares held directly by each of NB Private Markets V, NB Crossroads XXII, NB Gemini, and NB Select Opps II.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 is filed jointly by NB Alternatives Advisers LLC ("NBAA"), NB Crossroads Private Markets Fund V Holdings LP ("NB Private Markets V"), NB Crossroads XXII - MC Holdings LP ("NB Crossroads XXII"), NB Gemini Fund LP ("NB Gemini"), and NB Select Opps II MHF LP ("NB Select Opps II") (collectively, the "Reporting Persons").

F2: The Reporting Persons state that neither the filing of this statement nor anything herein shall be deemed an admission that such persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise, the beneficial owners of any securities covered by this statement. The Reporting Persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such persons in such securities.

F3: The Reporting Persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to Solo Brands, Inc. (the "Issuer") or securities of the Issuer.

F4: On May 16, 2023, pursuant to an underwriting agreement (the "Underwriting Agreement"), which is attached as Exhibit 1.1 to the Issuer's Form 8-K filed with the Securities and Exchange Commission (the "SEC") on May 12, 2023, entered into by the Issuer in connection with a registered secondary offering and sale of shares of Class A common stock of the Issuer, $0.001 par value per share ("Shares") by NB Private Markets V, NB Crossroads XXII, NB Gemini, and NB Select Opps II (collectively, the "NB Parties") and certain other selling stockholders listed on Schedule B to the Underwriting Agreement, the underwriters purchased from the NB Parties at a purchase price of $5.25 per share, less the underwriters' discount of $0.25 per share,

F5: (Continued from footnote 4) (the "Offering Price"), (i) 209,087 Shares, that were held directly by NB Private Markets V, (ii) 543,653 Shares that were held directly by NB Crossroads XXII, (iii) 1,610,040 Shares that were held directly by NB Gemini, and (iv) 1,819,126 Shares that were held directly by NB Select Opps II.

F6: Consists of (i) 135,043 Shares, held directly by NB Private Markets V, (ii) 351,130 Shares held directly by NB Crossroads XXII, (iii) 1,039,879 Shares held directly by NB Gemini, and (iv) 1,174,923 Shares held directly by NB Select Opps II.

F7: NBAA exercises dispositive and voting power with respect to the Shares held by each of the other Reporting Persons and, as a result, may be deemed to beneficially own the Shares held directly by each of NB Private Markets V, NB Crossroads XXII, NB Gemini, and NB Select Opps II.

F8: In addition, on May 16, 2023, pursuant to a privately negotiated Stock Purchase Agreement (the "Purchase Agreement"), which is attached as Exhibit 10.1 to the Issuer's Form 8-K filed with the SEC on May 12, 2023, by and between the Issuer, the NB Parties and certain other selling stockholders, the Issuer repurchased from the NB Parties at a purchase price of equal to the Offering Price, (i) 103,680 Shares that were held directly by NB Private Markets V, (ii) 269,582 Shares that were held directly by NB Crossroads XXII, (iii) 798,373 Shares that were held directly by NB Gemini, and (iv) 902,054 Shares that were held directly by NB Select Opps II.

F9: Consists of (i) 31,363 Shares, held directly by NB Private Markets V, (ii) 81,548 Shares held directly by NB Crossroads XXII, (iii) 241,506 Shares held directly by NB Gemini, and (iv) 272,869 Shares held directly by NB Select Opps II. As a result of the transactions by the NB Parties pursuant to the Purchase Agreement and the Underwriting Agreement, the Reporting Persons will no longer be reporting persons.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 16, 2023 Filed May 19, 2023 00:10 UTC Solo Brands, Inc. DTC · Entity 8034 SaleClass A Common Stock 2,073,689 $5.00 $10,368,445.00
Disclosure

SEC source: 0000950170-23-023136 · ownership.xml · nonDerivative · entry 2

NB Alternatives Advisers LLC · CIK 0001469000 · 10% owner

NB Crossroads Private Markets Fund V Holdings LP · CIK 0001702885 · 10% owner

NB Crossroads XXII - MC Holdings LP · CIK 0001824070 · 10% owner

NB Gemini Fund LP · CIK 0001824077 · 10% owner

NB Select Opps II MHF LP · CIK 0001891175 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 627,286

F1 · security: This Form 4 is filed jointly by NB Alternatives Advisers LLC ("NBAA"), NB Crossroads Private Markets Fund V Holdings LP ("NB Private Markets V"), NB Crossroads XXII - MC Holdings LP ("NB Crossroads XXII"), NB Gemini Fund LP ("NB Gemini"), and NB Select Opps II MHF LP ("NB Select Opps II") (collectively, the "Reporting Persons").

F2 · security: The Reporting Persons state that neither the filing of this statement nor anything herein shall be deemed an admission that such persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise, the beneficial owners of any securities covered by this statement. The Reporting Persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such persons in such securities.

F3 · security: The Reporting Persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to Solo Brands, Inc. (the "Issuer") or securities of the Issuer.

F8 · shares: In addition, on May 16, 2023, pursuant to a privately negotiated Stock Purchase Agreement (the "Purchase Agreement"), which is attached as Exhibit 10.1 to the Issuer's Form 8-K filed with the SEC on May 12, 2023, by and between the Issuer, the NB Parties and certain other selling stockholders, the Issuer repurchased from the NB Parties at a purchase price of equal to the Offering Price, (i) 103,680 Shares that were held directly by NB Private Markets V, (ii) 269,582 Shares that were held directly by NB Crossroads XXII, (iii) 798,373 Shares that were held directly by NB Gemini, and (iv) 902,054 Shares that were held directly by NB Select Opps II.

F8 · price: In addition, on May 16, 2023, pursuant to a privately negotiated Stock Purchase Agreement (the "Purchase Agreement"), which is attached as Exhibit 10.1 to the Issuer's Form 8-K filed with the SEC on May 12, 2023, by and between the Issuer, the NB Parties and certain other selling stockholders, the Issuer repurchased from the NB Parties at a purchase price of equal to the Offering Price, (i) 103,680 Shares that were held directly by NB Private Markets V, (ii) 269,582 Shares that were held directly by NB Crossroads XXII, (iii) 798,373 Shares that were held directly by NB Gemini, and (iv) 902,054 Shares that were held directly by NB Select Opps II.

F9 · balance_after: Consists of (i) 31,363 Shares, held directly by NB Private Markets V, (ii) 81,548 Shares held directly by NB Crossroads XXII, (iii) 241,506 Shares held directly by NB Gemini, and (iv) 272,869 Shares held directly by NB Select Opps II. As a result of the transactions by the NB Parties pursuant to the Purchase Agreement and the Underwriting Agreement, the Reporting Persons will no longer be reporting persons.

F7 · ownership.direct: NBAA exercises dispositive and voting power with respect to the Shares held by each of the other Reporting Persons and, as a result, may be deemed to beneficially own the Shares held directly by each of NB Private Markets V, NB Crossroads XXII, NB Gemini, and NB Select Opps II.

F9 · ownership.direct: Consists of (i) 31,363 Shares, held directly by NB Private Markets V, (ii) 81,548 Shares held directly by NB Crossroads XXII, (iii) 241,506 Shares held directly by NB Gemini, and (iv) 272,869 Shares held directly by NB Select Opps II. As a result of the transactions by the NB Parties pursuant to the Purchase Agreement and the Underwriting Agreement, the Reporting Persons will no longer be reporting persons.

F7 · ownership.nature: NBAA exercises dispositive and voting power with respect to the Shares held by each of the other Reporting Persons and, as a result, may be deemed to beneficially own the Shares held directly by each of NB Private Markets V, NB Crossroads XXII, NB Gemini, and NB Select Opps II.

F9 · ownership.nature: Consists of (i) 31,363 Shares, held directly by NB Private Markets V, (ii) 81,548 Shares held directly by NB Crossroads XXII, (iii) 241,506 Shares held directly by NB Gemini, and (iv) 272,869 Shares held directly by NB Select Opps II. As a result of the transactions by the NB Parties pursuant to the Purchase Agreement and the Underwriting Agreement, the Reporting Persons will no longer be reporting persons.

Read SEC document
May 16, 2023 Filed May 19, 2023 00:10 UTC Solo Brands, Inc. DTC · Entity 8034 SaleClass A Common Stock 4,181,906 $5.00 $20,909,530.00
Disclosure

SEC source: 0000950170-23-023136 · ownership.xml · nonDerivative · entry 1

NB Alternatives Advisers LLC · CIK 0001469000 · 10% owner

NB Crossroads Private Markets Fund V Holdings LP · CIK 0001702885 · 10% owner

NB Crossroads XXII - MC Holdings LP · CIK 0001824070 · 10% owner

NB Gemini Fund LP · CIK 0001824077 · 10% owner

NB Select Opps II MHF LP · CIK 0001891175 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,700,975

F1 · security: This Form 4 is filed jointly by NB Alternatives Advisers LLC ("NBAA"), NB Crossroads Private Markets Fund V Holdings LP ("NB Private Markets V"), NB Crossroads XXII - MC Holdings LP ("NB Crossroads XXII"), NB Gemini Fund LP ("NB Gemini"), and NB Select Opps II MHF LP ("NB Select Opps II") (collectively, the "Reporting Persons").

F2 · security: The Reporting Persons state that neither the filing of this statement nor anything herein shall be deemed an admission that such persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise, the beneficial owners of any securities covered by this statement. The Reporting Persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such persons in such securities.

F3 · security: The Reporting Persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to Solo Brands, Inc. (the "Issuer") or securities of the Issuer.

F4 · shares: On May 16, 2023, pursuant to an underwriting agreement (the "Underwriting Agreement"), which is attached as Exhibit 1.1 to the Issuer's Form 8-K filed with the Securities and Exchange Commission (the "SEC") on May 12, 2023, entered into by the Issuer in connection with a registered secondary offering and sale of shares of Class A common stock of the Issuer, $0.001 par value per share ("Shares") by NB Private Markets V, NB Crossroads XXII, NB Gemini, and NB Select Opps II (collectively, the "NB Parties") and certain other selling stockholders listed on Schedule B to the Underwriting Agreement, the underwriters purchased from the NB Parties at a purchase price of $5.25 per share, less the underwriters' discount of $0.25 per share,

F5 · shares: (Continued from footnote 4) (the "Offering Price"), (i) 209,087 Shares, that were held directly by NB Private Markets V, (ii) 543,653 Shares that were held directly by NB Crossroads XXII, (iii) 1,610,040 Shares that were held directly by NB Gemini, and (iv) 1,819,126 Shares that were held directly by NB Select Opps II.

F4 · price: On May 16, 2023, pursuant to an underwriting agreement (the "Underwriting Agreement"), which is attached as Exhibit 1.1 to the Issuer's Form 8-K filed with the Securities and Exchange Commission (the "SEC") on May 12, 2023, entered into by the Issuer in connection with a registered secondary offering and sale of shares of Class A common stock of the Issuer, $0.001 par value per share ("Shares") by NB Private Markets V, NB Crossroads XXII, NB Gemini, and NB Select Opps II (collectively, the "NB Parties") and certain other selling stockholders listed on Schedule B to the Underwriting Agreement, the underwriters purchased from the NB Parties at a purchase price of $5.25 per share, less the underwriters' discount of $0.25 per share,

F5 · price: (Continued from footnote 4) (the "Offering Price"), (i) 209,087 Shares, that were held directly by NB Private Markets V, (ii) 543,653 Shares that were held directly by NB Crossroads XXII, (iii) 1,610,040 Shares that were held directly by NB Gemini, and (iv) 1,819,126 Shares that were held directly by NB Select Opps II.

F6 · balance_after: Consists of (i) 135,043 Shares, held directly by NB Private Markets V, (ii) 351,130 Shares held directly by NB Crossroads XXII, (iii) 1,039,879 Shares held directly by NB Gemini, and (iv) 1,174,923 Shares held directly by NB Select Opps II.

F6 · ownership.direct: Consists of (i) 135,043 Shares, held directly by NB Private Markets V, (ii) 351,130 Shares held directly by NB Crossroads XXII, (iii) 1,039,879 Shares held directly by NB Gemini, and (iv) 1,174,923 Shares held directly by NB Select Opps II.

F7 · ownership.direct: NBAA exercises dispositive and voting power with respect to the Shares held by each of the other Reporting Persons and, as a result, may be deemed to beneficially own the Shares held directly by each of NB Private Markets V, NB Crossroads XXII, NB Gemini, and NB Select Opps II.

F6 · ownership.nature: Consists of (i) 135,043 Shares, held directly by NB Private Markets V, (ii) 351,130 Shares held directly by NB Crossroads XXII, (iii) 1,039,879 Shares held directly by NB Gemini, and (iv) 1,174,923 Shares held directly by NB Select Opps II.

F7 · ownership.nature: NBAA exercises dispositive and voting power with respect to the Shares held by each of the other Reporting Persons and, as a result, may be deemed to beneficially own the Shares held directly by each of NB Private Markets V, NB Crossroads XXII, NB Gemini, and NB Select Opps II.

Read SEC document
June 14, 2021 Filed Jun 14, 2021 17:17 UTC BIORA THERAPEUTICS, INC. PROG · Entity 85047 PurchaseWarrant · Derivative 8,097,166 $2.47 Strike: $2.84 $20,000,000.02
Disclosure

SEC source: 0000899243-21-023629 · doc4.xml · derivative · entry 2

Athyrium Capital Management, LP · CIK 0001728001 · 10% owner

Ferrell Jeffrey · CIK 0001394967 · Director · 10% owner

Athyrium Capital Holdings, LLC · CIK 0001815216 · 10% owner

Athyrium Funds GP Holdings LLC · CIK 0001815225 · 10% owner

NB Alternatives Holdings LLC · CIK 0001815501 · 10% owner

Athyrium Opportunities Advisers LLC · CIK 0001815484 · 10% owner

Athyrium Opportunities III Acquisition LP · CIK 0001835266 · 10% owner

NB Alternatives Advisers LLC · CIK 0001469000 · 10% owner

NB Alternatives GP Holdings LLC · CIK 0001815407 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 8,097,166

Underlying: Common Stock · 8,097,166 shares

Expires 2026-06-14

F4 · security: The Warrant represents a right to buy 8,097,166 shares of the Issuer's common stock at an exercise price of $2.84 per share. The Warrant is exercisable at any time and from time to time prior to June 14, 2026.

F1 · price: The shares of the Issuer's common stock and the Warrant were purchased for $2.47 per unit, with each unit consisting of one share of the Issuer's common stock and the right to buy an additional share of the Issuer's common stock for the exercise price specified in the Warrant.

F4 · derivative.underlying: The Warrant represents a right to buy 8,097,166 shares of the Issuer's common stock at an exercise price of $2.84 per share. The Warrant is exercisable at any time and from time to time prior to June 14, 2026.

F4 · balance_after: The Warrant represents a right to buy 8,097,166 shares of the Issuer's common stock at an exercise price of $2.84 per share. The Warrant is exercisable at any time and from time to time prior to June 14, 2026.

F2 · ownership.nature: The 8,097,166 shares of the Issuer's common stock and the Warrant are directly owned by Athyrium Opportunities III Acquisition 2 LP. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities III Acquisition 2 LP. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC. Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and the President of Athyrium Opportunities Associates III GP LLC.

F3 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.

Read SEC document
June 14, 2021 Filed Jun 14, 2021 17:17 UTC BIORA THERAPEUTICS, INC. PROG · Entity 85047 PurchaseCommon Stock 8,097,166 $2.47 $20,000,000.02
Disclosure

SEC source: 0000899243-21-023629 · doc4.xml · nonDerivative · entry 1

Athyrium Capital Management, LP · CIK 0001728001 · 10% owner

Ferrell Jeffrey · CIK 0001394967 · Director · 10% owner

Athyrium Capital Holdings, LLC · CIK 0001815216 · 10% owner

Athyrium Funds GP Holdings LLC · CIK 0001815225 · 10% owner

NB Alternatives Holdings LLC · CIK 0001815501 · 10% owner

Athyrium Opportunities Advisers LLC · CIK 0001815484 · 10% owner

Athyrium Opportunities III Acquisition LP · CIK 0001835266 · 10% owner

NB Alternatives Advisers LLC · CIK 0001469000 · 10% owner

NB Alternatives GP Holdings LLC · CIK 0001815407 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 36,396,907

F1 · price: The shares of the Issuer's common stock and the Warrant were purchased for $2.47 per unit, with each unit consisting of one share of the Issuer's common stock and the right to buy an additional share of the Issuer's common stock for the exercise price specified in the Warrant.

F2 · ownership.nature: The 8,097,166 shares of the Issuer's common stock and the Warrant are directly owned by Athyrium Opportunities III Acquisition 2 LP. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities III Acquisition 2 LP. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC. Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and the President of Athyrium Opportunities Associates III GP LLC.

F3 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.

Read SEC document
June 01, 2021 Filed Jun 3, 2021 16:41 UTC BIORA THERAPEUTICS, INC. PROG · Entity 85047 PurchaseCommon Stock 961,807 $2.86 $2,750,768.02
Disclosure

SEC source: 0000899243-21-021805 · doc4.xml · nonDerivative · entry 2

Athyrium Capital Management, LP · CIK 0001728001 · 10% owner

Ferrell Jeffrey · CIK 0001394967 · Director · 10% owner

Athyrium Capital Holdings, LLC · CIK 0001815216 · 10% owner

Athyrium Funds GP Holdings LLC · CIK 0001815225 · 10% owner

NB Alternatives Holdings LLC · CIK 0001815501 · 10% owner

Athyrium Opportunities Advisers LLC · CIK 0001815484 · 10% owner

Athyrium Opportunities III Acquisition LP · CIK 0001835266 · 10% owner

NB Alternatives Advisers LLC · CIK 0001469000 · 10% owner

NB Alternatives GP Holdings LLC · CIK 0001815407 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 28,299,741

F2 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.

F3 · ownership.nature: The 961,807 shares of the Issuer's common stock are held directly by Athyrium Opportunities III Co-Invest 1 LP. Athyrium Opportunities Associates Co-Invest LLC is the general partner of Athyrium Opportunities III Co-Invest 1 LP. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates Co-Invest LLC. Jeffrey A. Ferrell is the President of Athyrium Opportunities Associates Co-Invest LLC and the managing member of Athyrium Funds GP Holdings, LLC.

Read SEC document
June 01, 2021 Filed Jun 3, 2021 16:41 UTC BIORA THERAPEUTICS, INC. PROG · Entity 85047 PurchaseCommon Stock 306,308 $2.86 $876,040.88
Disclosure

SEC source: 0000899243-21-021805 · doc4.xml · nonDerivative · entry 1

Athyrium Capital Management, LP · CIK 0001728001 · 10% owner

Ferrell Jeffrey · CIK 0001394967 · Director · 10% owner

Athyrium Capital Holdings, LLC · CIK 0001815216 · 10% owner

Athyrium Funds GP Holdings LLC · CIK 0001815225 · 10% owner

NB Alternatives Holdings LLC · CIK 0001815501 · 10% owner

Athyrium Opportunities Advisers LLC · CIK 0001815484 · 10% owner

Athyrium Opportunities III Acquisition LP · CIK 0001835266 · 10% owner

NB Alternatives Advisers LLC · CIK 0001469000 · 10% owner

NB Alternatives GP Holdings LLC · CIK 0001815407 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 28,299,741

F1 · ownership.nature: The 306,308 shares of the Issuer's common stock are directly owned by Athyrium Opportunities III Acquisition LP. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities III Acquisition LP. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC. Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and the President of Athyrium Opportunities Associates III GP LLC.

F2 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.

Read SEC document
December 10, 2020 Filed Dec 14, 2020 21:15 UTC SolarWinds Corp SWI · Entity 80691 SaleCommon Stock 289,066 $21.97 $6,350,780.02
Disclosure

SEC source: 0000899243-20-033733 · doc4.xml · nonDerivative · entry 1

NB Alternatives Advisers LLC · CIK 0001469000 · 10% owner

NB Crossroads XX - MC Holdings LP · CIK 0001755836 · 10% owner

NB Crossroads XXI - MC Holdings LP · CIK 0001698419 · 10% owner

NB - Iowa's Public Universities LP · CIK 0001698425 · 10% owner

NB PEP Holdings Ltd · CIK 0001698427 · 10% owner

NB RP Co-Investment & Secondary Fund LLC · CIK 0001698444 · 10% owner

NB Sonoran Fund Limited Partnership · CIK 0001698437 · 10% owner

NB Wildcats Fund LP · CIK 0001698432 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 4,959,467

F1 · security: This Form 4 is filed jointly by NB Alternatives Advisers LLC ("NBAA"), NB Crossroads XX - MC Holdings LP ("NB Crossroads XX LP"), NB Crossroads XXI - MC Holdings LP ("NB Crossroads XXI LP"), NB - Iowa's Public Universities LP ("NB IPU LP"), NB PEP Holdings Limited ("NB PEP"), NB RP Co-Investment & Secondary Fund LLC ("NB RP Co-Investment"), NB Sonoran Fund Limited Partnership ("NB Sonoran LP"), NB Strategic Co-Investment Partners II Holdings LP ("NB Co-Investment II Holdings"), NB Wildcats Fund LP ("NB Wildcats LP"), Neuberger Berman Insurance Fund Series Interests of the SALI Multi-Series Fund L.P. ("NB SALI Series") and TfL Trustee Company Limited as Trustee of the TfL Pension Fund ("TfL Trustee") (collectively, the "Reporting Persons").

F2 · security: To enable all of the Reporting Persons to gain access to the Securities and Exchange Commission's electronic filing system (which only accepts a maximum of 10 joint filers per report), this report is the first of two identical reports relating to the same transactions. Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the outstanding shares of SolarWinds Corporation (the "Issuer"). Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. Neither the filing of this report nor anything herein shall be deemed an admission that any Reporting Person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose, the beneficial owner of such securities.

F3 · shares: On December 10, 2020, the Reporting Persons executed a joinder to a Stock Purchase Agreement to sell shares of common stock at a price of $21.97 per share, subject to potential adjustment under certain circumstances.

F4 · shares: Consists of (i) 23,125 shares sold by NB Crossroads XX LP, (ii) 8,672 shares sold by NB Crossroads XXI LP, (iii) 5,781 shares sold by NB IPU LP, (iv) 20,235 shares sold by NB PEP, (v) 5,781 shares sold by NB RP Co-Investment, (vi) 5,781 shares sold by NB Sonoran LP, (vii) 173,440 shares sold by NB Co-Investment II Holdings, (viii) 5,781 shares sold by NB Wildcats LP, (ix) 11,563 shares sold by NB SALI Series and (x) 28,907 shares sold by TfL Trustee.

F3 · price: On December 10, 2020, the Reporting Persons executed a joinder to a Stock Purchase Agreement to sell shares of common stock at a price of $21.97 per share, subject to potential adjustment under certain circumstances.

F5 · balance_after: Consists of (i) 396,757 shares held directly by NB Crossroads XX LP, (ii) 148,783 shares held directly by NB Crossroads XXI LP, (iii) 99,190 shares held directly by NB IPU LP, (iv) 347,162 shares held directly by NB PEP, (v) 99,190 shares held directly by NB RP Co-Investment, (vi) 99,190 shares held directly by NB Sonoran LP, (vii) 2,975,681 shares held directly by NB Co-Investment II Holdings, (viii) 99,190 shares held directly by NB Wildcats LP, (ix) 198,378 shares held directly by NB SALI Series and (x) 495,946 shares held directly by TfL Trustee.

F6 · ownership.direct: NBAA exercises dispositive and voting power with respect to the shares held by each of the other Reporting Persons and, as a result, may be deemed to beneficially own the shares held directly by NB Crossroads XX LP, NB Crossroads XXI LP, NB IPU LP, NB PEP, NB RP Co-Investment, NB Sonoran LP, NB Co-Investment II Holdings, NB Wildcats LP, NB SALI Series and TfL Trustee.

F6 · ownership.nature: NBAA exercises dispositive and voting power with respect to the shares held by each of the other Reporting Persons and, as a result, may be deemed to beneficially own the shares held directly by NB Crossroads XX LP, NB Crossroads XXI LP, NB IPU LP, NB PEP, NB RP Co-Investment, NB Sonoran LP, NB Co-Investment II Holdings, NB Wildcats LP, NB SALI Series and TfL Trustee.

Read SEC document
December 07, 2020 Filed Dec 9, 2020 17:35 UTC BIORA THERAPEUTICS, INC. PROG · Entity 85047 Purchase7.25% Convertible Senior Notes due 2025 · Derivative 78,500,000 $78,500,000.00 $6,162,250,000,000,000.00
Disclosure

SEC source: 0000899243-20-033184 · doc4.xml · derivative · entry 3

Athyrium Capital Management, LP · CIK 0001728001 · 10% owner

Ferrell Jeffrey · CIK 0001394967 · Director · 10% owner

Athyrium Capital Holdings, LLC · CIK 0001815216 · 10% owner

Athyrium Funds GP Holdings LLC · CIK 0001815225 · 10% owner

NB Alternatives Holdings LLC · CIK 0001815501 · 10% owner

Athyrium Opportunities Advisers LLC · CIK 0001815484 · 10% owner

Athyrium Opportunities III Acquisition LP · CIK 0001835266 · 10% owner

NB Alternatives Advisers LLC · CIK 0001469000 · 10% owner

NB Alternatives GP Holdings LLC · CIK 0001815407 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 78,500,000

Underlying: Common Stock · 21,823,737 shares

Expires 2025-12-01

F3 · derivative.exercise_price: The 7.25% Convertible Senior Notes due 2025 (the "Convertible Notes") are convertible into shares of the Issuer's common stock at an initial conversion rate of 278.0094 shares per $1,000 principal amount of Convertible Notes, which represents an initial conversion price of approximately $3.60 per share.

F5 · price: Athyrium Opportunities III Co-Invest 1 LP acquired such Convertible Notes in exchange for the discharge of amounts outstanding under the Issuer's credit and security agreement.

F2 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.

F6 · ownership.nature: The $78,500,000 aggregate principal amount of Convertible Notes is held directly by Athyrium Opportunities III Co-Invest 1 LP. Athyrium Opportunities Associates Co-Invest LLC is the general partner of Athyrium Opportunities III Co-Invest 1 LP. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates Co-Invest LLC. Jeffrey A. Ferrell is the President of Athyrium Opportunities Associates Co-Invest LLC and the managing member of Athyrium Funds GP Holdings, LLC.

Read SEC document
December 07, 2020 Filed Dec 9, 2020 17:35 UTC BIORA THERAPEUTICS, INC. PROG · Entity 85047 Purchase7.25% Convertible Senior Notes due 2025 · Derivative 25,000,000 $25,000,000.00 $625,000,000,000,000.00
Disclosure

SEC source: 0000899243-20-033184 · doc4.xml · derivative · entry 2

Athyrium Capital Management, LP · CIK 0001728001 · 10% owner

Ferrell Jeffrey · CIK 0001394967 · Director · 10% owner

Athyrium Capital Holdings, LLC · CIK 0001815216 · 10% owner

Athyrium Funds GP Holdings LLC · CIK 0001815225 · 10% owner

NB Alternatives Holdings LLC · CIK 0001815501 · 10% owner

Athyrium Opportunities Advisers LLC · CIK 0001815484 · 10% owner

Athyrium Opportunities III Acquisition LP · CIK 0001835266 · 10% owner

NB Alternatives Advisers LLC · CIK 0001469000 · 10% owner

NB Alternatives GP Holdings LLC · CIK 0001815407 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 25,000,000

Underlying: Common Stock · 6,950,235 shares

Expires 2025-12-01

F3 · derivative.exercise_price: The 7.25% Convertible Senior Notes due 2025 (the "Convertible Notes") are convertible into shares of the Issuer's common stock at an initial conversion rate of 278.0094 shares per $1,000 principal amount of Convertible Notes, which represents an initial conversion price of approximately $3.60 per share.

F2 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.

F4 · ownership.nature: The $25,000,000 aggregate principal amount of Convertible Notes is held directly by Athyrium Opportunities III Acquisition LP. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities III Acquisition LP. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC. Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and the President of Athyrium Opportunities Associates III GP LLC.

Read SEC document
December 07, 2020 Filed Dec 9, 2020 17:35 UTC BIORA THERAPEUTICS, INC. PROG · Entity 85047 PurchaseCommon Stock 4,128,440 $3.27 $13,499,998.80
Disclosure

SEC source: 0000899243-20-033184 · doc4.xml · nonDerivative · entry 1

Athyrium Capital Management, LP · CIK 0001728001 · 10% owner

Ferrell Jeffrey · CIK 0001394967 · Director · 10% owner

Athyrium Capital Holdings, LLC · CIK 0001815216 · 10% owner

Athyrium Funds GP Holdings LLC · CIK 0001815225 · 10% owner

NB Alternatives Holdings LLC · CIK 0001815501 · 10% owner

Athyrium Opportunities Advisers LLC · CIK 0001815484 · 10% owner

Athyrium Opportunities III Acquisition LP · CIK 0001835266 · 10% owner

NB Alternatives Advisers LLC · CIK 0001469000 · 10% owner

NB Alternatives GP Holdings LLC · CIK 0001815407 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 26,991,626

F1 · ownership.nature: The 4,128,440 shares of the Issuer's common stock are directly owned by Athyrium Opportunities III Acquisition 2 LP. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities III Acquisition 2 LP. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC. Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and the President of Athyrium Opportunities Associates III GP LLC.

F2 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.

Read SEC document
June 23, 2020 Filed Jun 25, 2020 16:25 UTC BIORA THERAPEUTICS, INC. PROG · Entity 85047 ConversionSeries B Preferred Stock · Derivative 101,736,263 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-017653 · doc4.xml · derivative · entry 5

Athyrium Capital Management, LP · CIK 0001728001 · 10% owner

Ferrell Jeffrey · CIK 0001394967 · Director · 10% owner

Athyrium Capital Holdings, LLC · CIK 0001815216 · 10% owner

Athyrium Funds GP Holdings LLC · CIK 0001815225 · 10% owner

Athyrium Opportunities Advisers LLC · CIK 0001815484 · 10% owner

NB Alternatives Advisers LLC · CIK 0001469000 · 10% owner

NB Alternatives GP Holdings LLC · CIK 0001815407 · 10% owner

NB Alternatives Holdings LLC · CIK 0001815501 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 0

Underlying: Common Stock · 18,319,853 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The Series B Preferred Stock converted into shares of the Issuer's common stock on a 0.162-for-one basis automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The Series B Preferred Stock has no expiration date.

F4 · shares: The Series B Preferred Stock converted into shares of the Issuer's common stock on a 0.162-for-one basis automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The Series B Preferred Stock has no expiration date.

F4 · price: The Series B Preferred Stock converted into shares of the Issuer's common stock on a 0.162-for-one basis automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The Series B Preferred Stock has no expiration date.

F4 · derivative.exercise_date: The Series B Preferred Stock converted into shares of the Issuer's common stock on a 0.162-for-one basis automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The Series B Preferred Stock has no expiration date.

F4 · derivative.expiration_date: The Series B Preferred Stock converted into shares of the Issuer's common stock on a 0.162-for-one basis automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The Series B Preferred Stock has no expiration date.

F2 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.

F5 · ownership.nature: The 4,211,977, 2,329,083, 7,603,040 and 4,175,753 shares of the Issuer's common stock issued on the conversion of the Series B Preferred Stock upon the closing of the initial public offering of the Issuer's common stock are held by Athyrium Opportunities Fund (A) LP, Athyrium Opportunities Fund (B) LP, Athyrium Opportunities III Acquisition 2 LP and Athyrium Opportunities III Co-Invest 1 LP, respectively. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities III Acquisition 2 LP.

F6 · ownership.nature: (continued from footnote 5) Athyrium Opportunities Associates Co-Invest LLC is the general partner of Athyrium Opportunities III Co-Invest 1 LP. Athyrium Opportunities Associates GP LLC is the general partner of Athyrium Opportunities Associates LP, which is the general partner of each of Athyrium Opportunities Fund (A) LP and Athyrium Opportunities Fund (B) LP. Athyrium Opportunities Advisers LLC is the investment adviser of each of Athyrium Opportunities Fund (A) LP and Athyrium Opportunities Fund (B) LP. Athyrium Capital Management, LP is a member of Athyrium Opportunities Associates GP LLC and an investment sub-adviser of Athyrium Opportunities Advisers LLC. NB Alternatives GP Holdings LLC is also a member of Athyrium Opportunities Associates GP LLC. NB Alternatives Holdings LLC is the sole member of NB Alternatives GP Holdings LLC and is a member of NB Alternatives Advisers LLC.

F7 · ownership.nature: (continued from footnote 6) NB Alternatives Advisers LLC is the sole member of Athyrium Opportunities Advisers LLC. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates Co-Invest LLC and Athyrium Opportunities Associates III GP LLC. Athyrium Capital Holdings, LLC is the general partner of Athyrium Capital Management, LP. Jeffrey A. Ferrell is the managing member of Athyrium Capital Holdings, LLC and Athyrium Funds GP Holdings, LLC and the President of Athyrium Capital Management, LP, Athyrium Opportunities Associates Co-Invest LLC, Athyrium Opportunities Associates III GP LLC, and Athyrium Opportunities Associates GP LLC.

Read SEC document
June 23, 2020 Filed Jun 25, 2020 16:25 UTC BIORA THERAPEUTICS, INC. PROG · Entity 85047 ConversionUnsecured Convertible Promissory Note · Derivative Not disclosed Not disclosed $15,000,000.00
Disclosure

SEC source: 0000899243-20-017653 · doc4.xml · derivative · entry 4

Athyrium Capital Management, LP · CIK 0001728001 · 10% owner

Ferrell Jeffrey · CIK 0001394967 · Director · 10% owner

Athyrium Capital Holdings, LLC · CIK 0001815216 · 10% owner

Athyrium Funds GP Holdings LLC · CIK 0001815225 · 10% owner

Athyrium Opportunities Advisers LLC · CIK 0001815484 · 10% owner

NB Alternatives Advisers LLC · CIK 0001469000 · 10% owner

NB Alternatives GP Holdings LLC · CIK 0001815407 · 10% owner

NB Alternatives Holdings LLC · CIK 0001815501 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: Not disclosed

Underlying: Common Stock · 1,250,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Unsecured Convertible Promissory Note converted into 1,250,000 shares of the Issuer's common stock automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. Prior to conversion, the Unsecured Convertible Promissory Note had a maturity date of May 8, 2022.

F3 · reported_value: The Unsecured Convertible Promissory Note converted into 1,250,000 shares of the Issuer's common stock automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. Prior to conversion, the Unsecured Convertible Promissory Note had a maturity date of May 8, 2022.

F3 · price: The Unsecured Convertible Promissory Note converted into 1,250,000 shares of the Issuer's common stock automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. Prior to conversion, the Unsecured Convertible Promissory Note had a maturity date of May 8, 2022.

F3 · derivative.exercise_date: The Unsecured Convertible Promissory Note converted into 1,250,000 shares of the Issuer's common stock automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. Prior to conversion, the Unsecured Convertible Promissory Note had a maturity date of May 8, 2022.

F3 · derivative.expiration_date: The Unsecured Convertible Promissory Note converted into 1,250,000 shares of the Issuer's common stock automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. Prior to conversion, the Unsecured Convertible Promissory Note had a maturity date of May 8, 2022.

F1 · ownership.nature: Athyrium Opportunities 2020 LP directly owns 4,583,333 shares of the Issuer's common stock. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities 2020 LP. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC. Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and President of Athyrium Opportunities Associates III GP LLC.

F2 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.

Read SEC document
June 23, 2020 Filed Jun 25, 2020 16:25 UTC BIORA THERAPEUTICS, INC. PROG · Entity 85047 ConversionCommon Stock 18,319,853 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-017653 · doc4.xml · nonDerivative · entry 3

Athyrium Capital Management, LP · CIK 0001728001 · 10% owner

Ferrell Jeffrey · CIK 0001394967 · Director · 10% owner

Athyrium Capital Holdings, LLC · CIK 0001815216 · 10% owner

Athyrium Funds GP Holdings LLC · CIK 0001815225 · 10% owner

Athyrium Opportunities Advisers LLC · CIK 0001815484 · 10% owner

NB Alternatives Advisers LLC · CIK 0001469000 · 10% owner

NB Alternatives GP Holdings LLC · CIK 0001815407 · 10% owner

NB Alternatives Holdings LLC · CIK 0001815501 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 23,303,346

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: The Series B Preferred Stock converted into shares of the Issuer's common stock on a 0.162-for-one basis automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The Series B Preferred Stock has no expiration date.

F2 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.

F5 · ownership.nature: The 4,211,977, 2,329,083, 7,603,040 and 4,175,753 shares of the Issuer's common stock issued on the conversion of the Series B Preferred Stock upon the closing of the initial public offering of the Issuer's common stock are held by Athyrium Opportunities Fund (A) LP, Athyrium Opportunities Fund (B) LP, Athyrium Opportunities III Acquisition 2 LP and Athyrium Opportunities III Co-Invest 1 LP, respectively. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities III Acquisition 2 LP.

F6 · ownership.nature: (continued from footnote 5) Athyrium Opportunities Associates Co-Invest LLC is the general partner of Athyrium Opportunities III Co-Invest 1 LP. Athyrium Opportunities Associates GP LLC is the general partner of Athyrium Opportunities Associates LP, which is the general partner of each of Athyrium Opportunities Fund (A) LP and Athyrium Opportunities Fund (B) LP. Athyrium Opportunities Advisers LLC is the investment adviser of each of Athyrium Opportunities Fund (A) LP and Athyrium Opportunities Fund (B) LP. Athyrium Capital Management, LP is a member of Athyrium Opportunities Associates GP LLC and an investment sub-adviser of Athyrium Opportunities Advisers LLC. NB Alternatives GP Holdings LLC is also a member of Athyrium Opportunities Associates GP LLC. NB Alternatives Holdings LLC is the sole member of NB Alternatives GP Holdings LLC and is a member of NB Alternatives Advisers LLC.

F7 · ownership.nature: (continued from footnote 6) NB Alternatives Advisers LLC is the sole member of Athyrium Opportunities Advisers LLC. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates Co-Invest LLC and Athyrium Opportunities Associates III GP LLC. Athyrium Capital Holdings, LLC is the general partner of Athyrium Capital Management, LP. Jeffrey A. Ferrell is the managing member of Athyrium Capital Holdings, LLC and Athyrium Funds GP Holdings, LLC and the President of Athyrium Capital Management, LP, Athyrium Opportunities Associates Co-Invest LLC, Athyrium Opportunities Associates III GP LLC, and Athyrium Opportunities Associates GP LLC.

Read SEC document
June 23, 2020 Filed Jun 25, 2020 16:25 UTC BIORA THERAPEUTICS, INC. PROG · Entity 85047 ConversionCommon Stock 1,250,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-017653 · doc4.xml · nonDerivative · entry 2

Athyrium Capital Management, LP · CIK 0001728001 · 10% owner

Ferrell Jeffrey · CIK 0001394967 · Director · 10% owner

Athyrium Capital Holdings, LLC · CIK 0001815216 · 10% owner

Athyrium Funds GP Holdings LLC · CIK 0001815225 · 10% owner

Athyrium Opportunities Advisers LLC · CIK 0001815484 · 10% owner

NB Alternatives Advisers LLC · CIK 0001469000 · 10% owner

NB Alternatives GP Holdings LLC · CIK 0001815407 · 10% owner

NB Alternatives Holdings LLC · CIK 0001815501 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 23,303,346

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: The Unsecured Convertible Promissory Note converted into 1,250,000 shares of the Issuer's common stock automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. Prior to conversion, the Unsecured Convertible Promissory Note had a maturity date of May 8, 2022.

F1 · ownership.nature: Athyrium Opportunities 2020 LP directly owns 4,583,333 shares of the Issuer's common stock. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities 2020 LP. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC. Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and President of Athyrium Opportunities Associates III GP LLC.

F2 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.

Read SEC document
June 23, 2020 Filed Jun 25, 2020 16:25 UTC BIORA THERAPEUTICS, INC. PROG · Entity 85047 PurchaseCommon Stock 3,333,333 $15.00 $49,999,995.00
Disclosure

SEC source: 0000899243-20-017653 · doc4.xml · nonDerivative · entry 1

Athyrium Capital Management, LP · CIK 0001728001 · 10% owner

Ferrell Jeffrey · CIK 0001394967 · Director · 10% owner

Athyrium Capital Holdings, LLC · CIK 0001815216 · 10% owner

Athyrium Funds GP Holdings LLC · CIK 0001815225 · 10% owner

Athyrium Opportunities Advisers LLC · CIK 0001815484 · 10% owner

NB Alternatives Advisers LLC · CIK 0001469000 · 10% owner

NB Alternatives GP Holdings LLC · CIK 0001815407 · 10% owner

NB Alternatives Holdings LLC · CIK 0001815501 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 23,303,346

F1 · ownership.nature: Athyrium Opportunities 2020 LP directly owns 4,583,333 shares of the Issuer's common stock. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities 2020 LP. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC. Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and President of Athyrium Opportunities Associates III GP LLC.

F2 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.

Read SEC document
May 28, 2019 Filed May 30, 2019 21:00 UTC SolarWinds Corp SWI · Entity 80691 SaleCommon Stock 302,419 $17.42 $5,266,626.89
Disclosure

SEC source: 0000899243-19-015187 · doc4.xml · nonDerivative · entry 1

NB Alternatives Advisers LLC · CIK 0001469000 · 10% owner

NB Crossroads XX - MC Holdings LP · CIK 0001755836 · 10% owner

NB Crossroads XXI - MC Holdings LP · CIK 0001698419 · 10% owner

NB - Iowa's Public Universities LP · CIK 0001698425 · 10% owner

NB PEP Holdings Ltd · CIK 0001698427 · 10% owner

NB RP Co-Investment & Secondary Fund LLC · CIK 0001698444 · 10% owner

NB Sonoran Fund Limited Partnership · CIK 0001698437 · 10% owner

NB Wildcats Fund LP · CIK 0001698432 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 5,248,533

F1 · security: This Form 4 is filed jointly by NB Alternatives Advisers LLC ("NBAA"), NB Crossroads XX - MC Holdings LP ("NB Crossroads XX LP"), NB Crossroads XXI - MC Holdings LP ("NB Crossroads XXI LP"), NB - Iowa's Public Universities LP ("NB IPU LP"), NB PEP Holdings Limited ("NB PEP"), NB RP Co-Investment & Secondary Fund LLC ("NB RP Co-Investment"), NB Sonoran Fund Limited Partnership ("NB Sonoran LP"), NB Strategic Co-Investment Partners II Holdings LP ("NB Co-Investment II Holdings"), NB Wildcats Fund LP ("NB Wildcats LP"), Neuberger Berman Insurance Fund Series Interests of the SALI Multi-Series Fund, L.P. ("NB SALI Series") and TfL Trustee Company Limited as Trustee of the TfL Pension Fund ("TfL Trustee") (collectively, the "Reporting Persons").

F2 · security: To enable all of the Reporting Persons to gain access to the Securities and Exchange Commission's electronic filing system (which only accepts a maximum of 10 joint filers per report), this report is the first of two identical reports relating to the same transactions. Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the outstanding shares of SolarWinds Corporation (the "Issuer"). Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. Neither the filing of this report nor anything herein shall be deemed an admission that any Reporting Person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose, the beneficial owner of such securities.

F3 · shares: Consists of (i) 24,194 shares sold by NB Crossroads XX LP, (ii) 9,073 shares sold by NB Crossroads XXI LP, (iii) 6,048 shares sold by NB IPU LP, (iv) 21,169 shares sold by NB PEP, (v) 6,048 shares sold by NB RP Co-Investment, (vi) 6,048 shares sold by NB Sonoran LP, (vii) 181,452 shares sold by NB Co-Investment II Holdings, (viii) 6,048 shares sold by NB Wildcats LP, (ix) 12,097 shares sold by NB SALI Series and (x) 30,242 shares sold by TfL Trustee.

F4 · balance_after: Consists of (i) 419,882 shares held directly by NB Crossroads XX LP, (ii) 157,455 shares held directly by NB Crossroads XXI LP, (iii) 104,971 shares held directly by NB IPU LP, (iv) 367,397 shares held directly by NB PEP, (v) 104,971 shares held directly by NB RP Co-Investment, (vi) 104,971 shares held directly by NB Sonoran LP, (vii) 3,149,121 shares held directly by NB Co-Investment II Holdings, (viii) 104,971 shares held directly by NB Wildcats LP, (ix) 209,941 shares held directly by NB SALI Series and (x) 524,853 shares held directly by TfL Trustee.

F5 · ownership.direct: NBAA exercises dispositive and voting power with respect to the shares held by each of the other Reporting Persons and, as a result, may be deemed to beneficially own the shares held directly by NB Crossroads XX LP, NB Crossroads XXI LP, NB IPU LP, NB PEP, NB RP Co-Investment, NB Sonoran LP, NB Co-Investment II Holdings, NB Wildcats LP, NB SALI Series and TfL Trustee.

F5 · ownership.nature: NBAA exercises dispositive and voting power with respect to the shares held by each of the other Reporting Persons and, as a result, may be deemed to beneficially own the shares held directly by NB Crossroads XX LP, NB Crossroads XXI LP, NB IPU LP, NB PEP, NB RP Co-Investment, NB Sonoran LP, NB Co-Investment II Holdings, NB Wildcats LP, NB SALI Series and TfL Trustee.

Read SEC document
October 23, 2018 Filed Oct 24, 2018 20:16 UTC SolarWinds Corp SWI · Entity 80691 ConversionClass A Common Stock · Derivative 53,292 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-18-027350 · doc4.xml · derivative · entry 2

NB Alternatives Advisers LLC · CIK 0001469000 · 10% owner

NB Crossroads XX - MC Holdings LP · CIK 0001755836 · 10% owner

NB Crossroads XXI - MC Holdings LP · CIK 0001698419 · 10% owner

NB - Iowa's Public Universities LP · CIK 0001698425 · 10% owner

NB PEP Holdings Ltd · CIK 0001698427 · 10% owner

NB RP Co-Investment & Secondary Fund LLC · CIK 0001698444 · 10% owner

NB Sonoran Fund Limited Partnership · CIK 0001698437 · 10% owner

NB Wildcats Fund LP · CIK 0001698432 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 3,561,571 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This Form 4 is filed jointly by NB Alternatives Advisers LLC ("NBAA"), NB Crossroads XX - MC Holdings LP ("NB Crossroads XX LP"), NB Crossroads XXI - MC Holdings LP ("NB Crossroads XXI LP"), NB - Iowa's Public Universities LP ("NB IPU LP"), NB PEP Holdings Limited ("NB PEP"), NB RP Co-Investment & Secondary Fund LLC ("NB RP Co-Investment"), NB Sonoran Fund Limited Partnership ("NB Sonoran LP"), NB Strategic Co-Investment Partners II Holdings LP ("NB Co-Investment II Holdings"), NB Wildcats Fund LP ("NB Wildcats LP"), Neuberger Berman Insurance Fund Series Interests of the SALI Multi-Series Fund, L.P. ("NB SALI Series") and TfL Trustee Company Limited as Trustee of the TfL Pension Fund ("TfL Trustee") (collectively, the "Reporting Persons").

F2 · security: To enable all of the Reporting Persons to gain access to the Securities and Exchange Commission's electronic filing system (which only accepts a maximum of 10 joint filers per report), this report is the first of two identical reports relating to the same transactions. Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the outstanding shares of SolarWinds Corporation (the "Issuer"). Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. Neither the filing of this report nor anything herein shall be deemed an admission that any Reporting Person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose, the beneficial owner of such securities.

F4 · derivative.exercise_price: Immediately prior to the completion of the Issuer's initial public offering, each outstanding share of Class A Common Stock automatically converted into a number of shares of Class B Common Stock equal to the result of the liquidation value of such share of Class A Common Stock divided by $19.00. The liquidation value for each share of Class A Common Stock was equal to $1,000 plus accrued and unpaid dividends on such share of Class A Common Stock through October 18, 2018. In addition, the shares of the Issuer's Class A Common Stock were convertible, at the option of the holder, into shares of Class B Common Stock for a specified period of time ending on November 7, 2018.

F4 · kind: Immediately prior to the completion of the Issuer's initial public offering, each outstanding share of Class A Common Stock automatically converted into a number of shares of Class B Common Stock equal to the result of the liquidation value of such share of Class A Common Stock divided by $19.00. The liquidation value for each share of Class A Common Stock was equal to $1,000 plus accrued and unpaid dividends on such share of Class A Common Stock through October 18, 2018. In addition, the shares of the Issuer's Class A Common Stock were convertible, at the option of the holder, into shares of Class B Common Stock for a specified period of time ending on November 7, 2018.

F8 · shares: Consists of (i) 4,263 shares held directly by NB Crossroads XX LP, (ii) 1,599 shares held directly by NB Crossroads XXI LP, (iii) 1,066 shares held directly by NB IPU LP, (iv) 3,730 shares held directly by NB PEP, (v) 1,066 shares held directly by NB RP Co-Investment, (vi) 1,066 shares held directly by NB Sonoran LP, (vii) 31,975 shares held directly by NB Co-Investment II Holdings, (viii) 1,066 shares held directly by NB Wildcats LP, (ix) 2,132 shares held directly by NB SALI Series and (x) 5,329 shares held directly by TfL Trustee.

F4 · price: Immediately prior to the completion of the Issuer's initial public offering, each outstanding share of Class A Common Stock automatically converted into a number of shares of Class B Common Stock equal to the result of the liquidation value of such share of Class A Common Stock divided by $19.00. The liquidation value for each share of Class A Common Stock was equal to $1,000 plus accrued and unpaid dividends on such share of Class A Common Stock through October 18, 2018. In addition, the shares of the Issuer's Class A Common Stock were convertible, at the option of the holder, into shares of Class B Common Stock for a specified period of time ending on November 7, 2018.

F4 · derivative.exercise_date: Immediately prior to the completion of the Issuer's initial public offering, each outstanding share of Class A Common Stock automatically converted into a number of shares of Class B Common Stock equal to the result of the liquidation value of such share of Class A Common Stock divided by $19.00. The liquidation value for each share of Class A Common Stock was equal to $1,000 plus accrued and unpaid dividends on such share of Class A Common Stock through October 18, 2018. In addition, the shares of the Issuer's Class A Common Stock were convertible, at the option of the holder, into shares of Class B Common Stock for a specified period of time ending on November 7, 2018.

F4 · derivative.expiration_date: Immediately prior to the completion of the Issuer's initial public offering, each outstanding share of Class A Common Stock automatically converted into a number of shares of Class B Common Stock equal to the result of the liquidation value of such share of Class A Common Stock divided by $19.00. The liquidation value for each share of Class A Common Stock was equal to $1,000 plus accrued and unpaid dividends on such share of Class A Common Stock through October 18, 2018. In addition, the shares of the Issuer's Class A Common Stock were convertible, at the option of the holder, into shares of Class B Common Stock for a specified period of time ending on November 7, 2018.

F3 · derivative.underlying: Immediately prior to the completion of the Issuer's initial public offering and following the conversion of the Issuer's Class A Common Stock into Class B Common Stock, each share of Class B Common Stock was reclassified into one share of Common Stock.

F4 · derivative.underlying_shares: Immediately prior to the completion of the Issuer's initial public offering, each outstanding share of Class A Common Stock automatically converted into a number of shares of Class B Common Stock equal to the result of the liquidation value of such share of Class A Common Stock divided by $19.00. The liquidation value for each share of Class A Common Stock was equal to $1,000 plus accrued and unpaid dividends on such share of Class A Common Stock through October 18, 2018. In addition, the shares of the Issuer's Class A Common Stock were convertible, at the option of the holder, into shares of Class B Common Stock for a specified period of time ending on November 7, 2018.

F5 · derivative.underlying_shares: Consists of (i) 284,926 shares held directly by NB Crossroads XX LP, (ii) 106,847 shares held directly by NB Crossroads XXI LP, (iii) 71,231 shares held directly by NB IPU LP, (iv) 249,309 shares held directly by NB PEP, (v) 71,231 shares held directly by NB RP Co-Investment, (vi) 71,231 shares held directly by NB Sonoran LP, (vii) 2,136,945 shares held directly by NB Co-Investment II Holdings, (viii) 71,231 shares held directly by NB Wildcats LP, (ix) 142,463 shares held directly by NB SALI Series and (x) 356,157 shares held directly by TfL Trustee.

F7 · ownership.nature: NBAA exercises dispositive and voting power with respect to the shares held by each of the other Reporting Persons and, as a result, may be deemed to beneficially own the shares held directly by NB Crossroads XX LP, NB Crossroads XXI LP, NB IPU LP, NB PEP, NB RP Co-Investment, NB Sonoran LP, NB Co-Investment II Holdings, NB Wildcats LP, NB SALI Series and TfL Trustee.

Read SEC document
October 23, 2018 Filed Oct 24, 2018 20:16 UTC SolarWinds Corp SWI · Entity 80691 ConversionCommon Stock 3,561,571 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-18-027350 · doc4.xml · nonDerivative · entry 1

NB Alternatives Advisers LLC · CIK 0001469000 · 10% owner

NB Crossroads XX - MC Holdings LP · CIK 0001755836 · 10% owner

NB Crossroads XXI - MC Holdings LP · CIK 0001698419 · 10% owner

NB - Iowa's Public Universities LP · CIK 0001698425 · 10% owner

NB PEP Holdings Ltd · CIK 0001698427 · 10% owner

NB RP Co-Investment & Secondary Fund LLC · CIK 0001698444 · 10% owner

NB Sonoran Fund Limited Partnership · CIK 0001698437 · 10% owner

NB Wildcats Fund LP · CIK 0001698432 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 5,550,952

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This Form 4 is filed jointly by NB Alternatives Advisers LLC ("NBAA"), NB Crossroads XX - MC Holdings LP ("NB Crossroads XX LP"), NB Crossroads XXI - MC Holdings LP ("NB Crossroads XXI LP"), NB - Iowa's Public Universities LP ("NB IPU LP"), NB PEP Holdings Limited ("NB PEP"), NB RP Co-Investment & Secondary Fund LLC ("NB RP Co-Investment"), NB Sonoran Fund Limited Partnership ("NB Sonoran LP"), NB Strategic Co-Investment Partners II Holdings LP ("NB Co-Investment II Holdings"), NB Wildcats Fund LP ("NB Wildcats LP"), Neuberger Berman Insurance Fund Series Interests of the SALI Multi-Series Fund, L.P. ("NB SALI Series") and TfL Trustee Company Limited as Trustee of the TfL Pension Fund ("TfL Trustee") (collectively, the "Reporting Persons").

F2 · security: To enable all of the Reporting Persons to gain access to the Securities and Exchange Commission's electronic filing system (which only accepts a maximum of 10 joint filers per report), this report is the first of two identical reports relating to the same transactions. Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the outstanding shares of SolarWinds Corporation (the "Issuer"). Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. Neither the filing of this report nor anything herein shall be deemed an admission that any Reporting Person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose, the beneficial owner of such securities.

F3 · security: Immediately prior to the completion of the Issuer's initial public offering and following the conversion of the Issuer's Class A Common Stock into Class B Common Stock, each share of Class B Common Stock was reclassified into one share of Common Stock.

F4 · kind: Immediately prior to the completion of the Issuer's initial public offering, each outstanding share of Class A Common Stock automatically converted into a number of shares of Class B Common Stock equal to the result of the liquidation value of such share of Class A Common Stock divided by $19.00. The liquidation value for each share of Class A Common Stock was equal to $1,000 plus accrued and unpaid dividends on such share of Class A Common Stock through October 18, 2018. In addition, the shares of the Issuer's Class A Common Stock were convertible, at the option of the holder, into shares of Class B Common Stock for a specified period of time ending on November 7, 2018.

F5 · shares: Consists of (i) 284,926 shares held directly by NB Crossroads XX LP, (ii) 106,847 shares held directly by NB Crossroads XXI LP, (iii) 71,231 shares held directly by NB IPU LP, (iv) 249,309 shares held directly by NB PEP, (v) 71,231 shares held directly by NB RP Co-Investment, (vi) 71,231 shares held directly by NB Sonoran LP, (vii) 2,136,945 shares held directly by NB Co-Investment II Holdings, (viii) 71,231 shares held directly by NB Wildcats LP, (ix) 142,463 shares held directly by NB SALI Series and (x) 356,157 shares held directly by TfL Trustee.

F4 · price: Immediately prior to the completion of the Issuer's initial public offering, each outstanding share of Class A Common Stock automatically converted into a number of shares of Class B Common Stock equal to the result of the liquidation value of such share of Class A Common Stock divided by $19.00. The liquidation value for each share of Class A Common Stock was equal to $1,000 plus accrued and unpaid dividends on such share of Class A Common Stock through October 18, 2018. In addition, the shares of the Issuer's Class A Common Stock were convertible, at the option of the holder, into shares of Class B Common Stock for a specified period of time ending on November 7, 2018.

F6 · balance_after: Consists of (i) 444,076 shares held directly by NB Crossroads XX LP, (ii) 166,528 shares held directly by NB Crossroads XXI LP, (iii) 111,019 shares held directly by NB IPU LP, (iv) 388,566 shares held directly by NB PEP, (v) 111,019 shares held directly by NB RP Co-Investment, (vi) 111,019 shares held directly by NB Sonoran LP, (vii) 3,330,573 shares held directly by NB Co-Investment II Holdings, (viii) 111,019 shares held directly by NB Wildcats LP, (ix) 222,038 shares held directly by NB SALI Series and (x) 555,095 shares held directly by TfL Trustee.

F7 · ownership.direct: NBAA exercises dispositive and voting power with respect to the shares held by each of the other Reporting Persons and, as a result, may be deemed to beneficially own the shares held directly by NB Crossroads XX LP, NB Crossroads XXI LP, NB IPU LP, NB PEP, NB RP Co-Investment, NB Sonoran LP, NB Co-Investment II Holdings, NB Wildcats LP, NB SALI Series and TfL Trustee.

F7 · ownership.nature: NBAA exercises dispositive and voting power with respect to the shares held by each of the other Reporting Persons and, as a result, may be deemed to beneficially own the shares held directly by NB Crossroads XX LP, NB Crossroads XXI LP, NB IPU LP, NB PEP, NB RP Co-Investment, NB Sonoran LP, NB Co-Investment II Holdings, NB Wildcats LP, NB SALI Series and TfL Trustee.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.